Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 19;48(5):E390-E399.
doi: 10.1503/jpn.230062. Print 2023 Sep-Oct.

Correlation of the methylomic signature of smoking during pregnancy with clinical traits in ADHD

Affiliations

Correlation of the methylomic signature of smoking during pregnancy with clinical traits in ADHD

Boris Chaumette et al. J Psychiatry Neurosci. .

Abstract

Background: Attention deficit/hyperactivity disorder (ADHD) is a highly prevalent childhood disorder. Maternal smoking during pregnancy is a replicated environmental risk factor for this disorder. It is also a robust modifier of gene methylation during the prenatal developmental period. In this study, we sought to identify loci differentially methylated by maternal smoking during pregnancy and relate their methylation levels to various behavioural and physical outcomes relevant to ADHD.

Methods: We extracted DNA from blood samples from children diagnosed with ADHD and deeply phenotyped. Genome-wide DNA methylation was assessed using Infinium MethylationEPIC BeadChip. Maternal smoking during pregnancy was self-declared and assessed retrospectively.

Results: Our sample included 231 children with ADHD. Statistically significant differences in DNA methylation between children exposed or not to maternal smoking during pregnancy were detected in 3457 CpGs. We kept 30 CpGs with at least 5% of methylation difference between the 2 groups for further analysis. Six genes were associated with varied phenotypes of clinical relevance to ADHD. The levels of DNA methylation in RUNX1 were positively correlated with the CBCL scores, and DNA methylation in MYO1G correlated positively with the score at the Conners rating scale. Methylation level in a CpG located in GFI1 correlated with birthweight, a risk factor for ADHD. Differentially methylated regions were also identified and confirmed the association of RUNX1 methylation levels with the CBCL score.

Limitations: The study has several limitations, including the retrospective recall with self-report of maternal smoking during pregnancy as well as the grouping of individuals of varying age and developmental stage and of both males and females. In addition, the correlation design prevents the building of causation models.

Conclusion: This study provides evidence for the association between the level of methylation at specific loci and quantitative dimensions highly relevant for ADHD as well as birth weight, a measure that has already been associated with increased risk for ADHD. Our results provide further support to public health educational initiatives to stop maternal smoking during pregnancy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: B. Chaumette has received research funding from the Fondation Bettencourt Schueller (180 000€/4 yr) and speaking fees from Janssen-Cilag, Lundbeck and Eisai, outside the submitted work. He has no direct employment in profit organizations nor consultancies. N. Grizenko reports receiving research funding from the Canadian Institutes of Health Research (CIHR) and is a member of the advisory board for Purdue and Shire. A. Labbe is an associate editor of JPN. She was not involved in the review or decision to accept this manuscript for publication. R. Joober reports having received research funding from CIHR. He is on the advisory boards and speakers’ bureaus of Pfizer, Janssen Ortho, BMS, Sunovion, Otsuka, Lundbeck, Perdue and Myelin. He has received grant funding from them and from AstraZeneca and HLS. He has received honoraria from Janssen Canada, Shire, Lundbeck, Otsuka, Pfizer and from Perdue for CME presentations and royalties for Henry Stewart talks. No other competing interests were declared.

Figures

Figure 1
Figure 1
Manhattan plot of the methylation epigenome-wide association study comparing children with attention-deficit/hyperactivity disorder (ADHD) who were exposed or not exposed to maternal smoking during pregnancy.

References

    1. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012;9:490–9. - PMC - PubMed
    1. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237–48. - PubMed
    1. Thapar A, Cooper M, Eyre O, et al. . What have we learnt about the causes of ADHD? J Child Psychol Psychiatry 2013;54:3–16. - PMC - PubMed
    1. Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry 2019;24:562–75. - PMC - PubMed
    1. Demontis D, Walters GB, Athanasiadis G, et al. . Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet 2023;55:198–208. - PMC - PubMed

Publication types

Substances